SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending sharply upwards following exceptionally positive Phase 2 S-OLARIS trial data for sonelokimab in axial spondyloarthritis, which revealed "disease-modifying" potential and robust efficacy. The community is buzzing with expectations for significant upside, fueled by a major institutional buyback, strong financials, and the upcoming Investor Day, intensifying talks of a potential short squeeze and a "best-in-class" valuation.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is sparking intense debate following its earnings report, where the company announced a beta mortgage product and projected adjusted EBITDA profitability by Q2, electrifying bulls confident in its AI and capital-light transformation while bears remain skeptical of persistent losses and the iBuying model's viability amidst market volatility.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending amid fresh market uncertainty as new global tariffs announced by Trump following a Supreme Court ruling are sparking concerns over potential trade friction with allies like the EU and India. This sentiment is amplified by a significant pullback in Bitcoin, which some in the community see as a broader signal of financial system stress, with many actively debating whether the market will recover or face a deeper correction ahead of NVIDIA's crucial earnings report this week.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending due to a recent filing that would allow Trump's trust to sell a significant amount of stock and includes an evergreen provision for future share issuance, sparking active community discussion and widespread concerns over potential dilution and the company's long-term valuation.

Synthetix is a decentralized perpetual futures protocol built on Ethereum Mainnet. Synthetix uses a hybrid design — off-chain order matching on a high-performance CLOB with on-chain settlement — to deliver low latency, deep liquidity, and MEV-resistant execution while keeping custody and finality on Ethereum. Traders get CEX-like performance with on-chain security and composability. The protocol’s liquidity is provided by the Synthetix Liquidity Provider (SLP) vault and backstopped by staked SNX collateral, which underwrites the issuance of the sUSD stablecoin and the solvency of the SLP vault.

Synthetix Network 

Synthetix Network is currently gaining significant attention due to a recent pivotal update regarding its tokenomics and platform development. The community is actively discussing the confirmed end of token inflation with no more SNX to be minted, coupled with the upcoming implementation of buybacks coinciding with the launch of Perps v3. This fundamental shift towards a deflationary model and enhanced platform utility, alongside a recent high-profile trading competition with a $1 million prize, is fueling strong bullish sentiment and driving conversation among traders about its potential for growth.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor is seeing significant attention after reporting blowout earnings, strong guidance, and an ambitious capital expenditure outlook that reaffirms its central role in the AI supercycle, with investors also closely monitoring ongoing U.S.-Taiwan trade discussions that could further impact global chip supply.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is trending due to accelerating hyperscale orders for its 800G transceivers, notably from Amazon, alongside plans to significantly expand its AI data center manufacturing. The community is buzzing about potential short squeezes and higher price targets as the optical components sector plays a crucial role in AI infrastructure buildouts.

Pump.fun

Pump.fun (PUMP CRYPTO) is experiencing significant market conversation after news broke of a former developer's fraud sentencing and an intensifying lawsuit, fueling both strong calls to "pump it" by loyalists citing platform buybacks, and concerns about its legitimacy among skeptics.

Blue Owl Capital, Inc. operates as an alternative asset management firm. It provides investors access to asset management capital solutions through its Direct Lending and GP Capital Solutions products. The company offers a platform of capital solutions to both middle market companies and large alternative asset managers. The company was founded by Doug Irving Ostrover, Michael Rees and Craig W.Packer in 2009 and is headquartered in New York, NY.

Blue Owl Capital Inc - Ordinary Shares - Class A

Blue Owl Capital is actively discussed due to reported withdrawal restrictions in a private credit fund and concerns over financing major AI data center projects, fueling community fears about private credit market liquidity, while the company maintains it is strategically accelerating capital returns.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending as its Bysanti drug received FDA approval for bipolar I disorder and schizophrenia, notably gaining New Chemical Entity status and patent protection until 2044. The community is now keenly discussing the potential for a significant valuation re-rating, a short squeeze, and strong buyout interest from major pharma due to this and its promising GLP-1 nausea pipeline candidate.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bausch Health Companies Inc. shares (BHC) jumped over 7% in after-hours trading on Wednesday following a solid fourth-quarter earnings report that beat revenue estimates and reaffirmed strong guidance for 2025.The company posted Q4 revenue of $2.56 billion, surpassing the consensus estimate of $2.51 billion, while adjusted earnings per share (EPS) of $1.14 narrowly topped expectations of $1.13.&nbsp;Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) came in at $935 million, up from $869 million a year ago.CEO Thomas Appio highlighted 2024 as a year of "delivering on our commitments," with results landing at the high end of revenue guidance and exceeding expectations for adjusted EBITDA (excluding Bausch + Lomb) and operating cash flow.Salix, the company's gastrointestinal and hepatology division, generated $634 million in Q4 revenue, up 9% year-over-year. This was largely driven by Xifaxan, a treatment for irritable bowel syndrome and traveler's diarrhea, which posted 16% growth.&nbsp;The Solta segment, which includes medical aesthetics, saw Q4 revenue climb 34% to $138 million, fueled by strong demand in South Korea and China.For 2025, Bausch Health projects revenue between $9.90 billion and $10.15 billion, above the consensus estimate of $9.89 billion.&nbsp;The company also forecasts FY25 adjusted EBITDA between $3.525 billion and $3.675 billion.<figure class="image"><img style="aspect-ratio:1318/324;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/BHC_sentiment_and_message_volume_Feb_19_07562dbe77.png" alt="BHC sentiment and message volume Feb 19.png" width="1318" height="324"><figcaption>BHC sentiment and message volume Feb 19 | source: Stocktwits</figcaption></figure>Retail sentiment on Stocktwits turned 'extremely bullish' following the earnings report, with message volume spiking 1,900% on Wednesday.One user highlighted "very good organic revenue growth and solid guidance," expecting a strong bounce for the stock.&nbsp;Another hoped for a rally past $20 per share.<stembedurl>https://stocktwits.com/Neildc/message/604885428</stembedurl><stembedurl>https://stocktwits.com/Maxgluteal/message/604910108</stembedurl>However, BHC shares remain about 35% below analysts' average target price of $8.83.&nbsp;The stock has lost over 19% year-to-date.&nbsp;&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises

The company’s Solta segment, which includes medical aesthetics, saw Q4 revenue climb 34% to $138 million, fueled by strong demand in South Korea and China.

VSS
Vanguard FTSE All-World Ex-US Small Cap ETF

Feed

News

Sentiment

Fundamentals

Info

Latest VSS News

VSSVanguard FTSE All-World Ex-US Small Cap ETF